Elizabeth Hwang is a Gastroenterology physician affiliated with VA Palo Alto Health Care System. OpenAlex indexes 9 publications with 204 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Alway Building, Room M211
Stanford, CA 943052200
Telephone
650-721-6190Provider last certified this registry record 26 Apr 2024.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ERBE USA IncProgram year20231 payment
- INTERCEPT PHARMACEUTICALS, INC.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
52.2%Proton pump inhibitor17.6%Omeprazole59%Pantoprazole Sodium29%Esomeprazole Magnesium13%Part D<11 patientsRifamycin Antibacterial9%Xifaxan100%Part D≥16 patients+ 6 more classes in this area
Anti-infectives
25.2%Nucleoside and nucleotide reverse transcriptase inhibitors19.6%Vemlidy90%Tenofovir Disoproxil Fumarate10%Part D<11 patientsHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor5.7%Entecavir100%Part D<11 patientsCardiovascular
14.2%Loop diuretic6.7%Furosemide100%Part D≥15 patientsAldosterone antagonist (MRA)4.8%Spironolactone100%Part D≥11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2020–2023 per NIH RePORTER. The latest:
- Interrogating the role of Notch signaling in lung adenocarcinoma tumorigenesis
University of California, San Francisco
FY2023$52,694F30CA250157 - Interrogating the role of Notch signaling in lung adenocarcinoma tumorigenesis
University of California, San Francisco
FY2022$51,752F30CA250157 - Interrogating the role of Notch signaling in lung adenocarcinoma tumorigenesis
University of California, San Francisco
FY2021$37,799F30CA250157
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Early Virologic Responses and Hematologic Safety of Direct-Acting Antiviral Therapies in Veterans With Chronic Hepatitis C
Clinical Gastroenterology and Hepatology
2013 - Global Epidemiology of Hepatitis B Virus (HBV) Infection
North American Journal of Medicine and Science
2012 - Assessment and Utilization of Rapid Virologic Response in US Veterans With Chronic Hepatitis C
Journal of Clinical Gastroenterology
2012 - Implications of rapid virological response in hepatitis C therapy in the US veteran population
Alimentary Pharmacology & Therapeutics
2011
Similar KOLs
Other experts from the same institution or the same specialty.
David Relman, MD
VA Palo Alto Health Care System
Ramsey Cheung, MD
VA Palo Alto Health Care System
Mark Nicolls, MD
VA Palo Alto Health Care System
Odette Harris, MD
VA Palo Alto Health Care System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”